Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein

Drug Discovery Today

Volumn 21, Issue 4, 2016, Pages 562-572

  Chang, Chung Ke ^a   Lo, Shou Chen ^b   Wang, Yong Sheng ^b   Hou, Ming Hon ^b  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; NUCLEOCAPSID PROTEIN; NUCLEOCAPSID PROTEIN, CORONAVIRUS;

CORONAVIRIDAE; CORONAVIRUS INFECTION; DRUG TARGETING; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; PROTEIN STRUCTURE; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS CAPSID; ANIMAL; CHEMISTRY; CORONAVIRUS INFECTIONS; HUMAN; METABOLISM;

ANIMALS; ANTIVIRAL AGENTS; CORONAVIRUS INFECTIONS; HUMANS; NUCLEOCAPSID PROTEINS;

EID: 84953438753     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2015.11.015     Document Type: Review

References (106)

1. D.K. Cherry, and et al. National Ambulatory Medical Care Survey: 2006 summary Natl. Health Stat. Report 3 2008 1 39
2. C-J. Hsiao, and et al. National Ambulatory Medical Care Survey: 2007 summary Natl. Health Stat. Report 27 2010 1 32
3. F. Canducci, and et al. Two-year prospective study of single infections and co-infections by respiratory syncytial virus and viruses identified recently in infants with acute respiratory disease J. Med. Virol. 80 2008 716 723
4. M. Jevsnik, and et al. Coronavirus infections in hospitalized pediatric patients with acute respiratory tract disease BMC Infect. Dis. 12 2012 365
5. Y. Matoba, and et al. Detection of the human coronavirus 229E, HKU1, NL63, and OC43 between 2010 and 2013 in Yamagata, Japan Jpn. J. Infect. Dis. 68 2015 138 141
6. S.K. Lau, and et al. Coronavirus HKU1 and other coronavirus infections in Hong Kong J. Clin. Microbiol. 44 2006 2063 2071
7. M. Kon, and et al. Detection of human coronavirus NL63 and OC43 in children with acute respiratory infections in Niigata, Japan, between 2010 and 2011 Jpn. J. Infect. Dis. 65 2012 270 272
8. E.R. Gaunt, and et al. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method J. Clin. Microbiol. 48 2010 2940 2947
9. H.K. Talbot, and et al. The pediatric burden of human coronaviruses evaluated for twenty years Pediatr. Infect. Dis. J. 28 2009 682 687
10. R. Dijkman, and et al. The dominance of human coronavirus OC43 and NL63 infections in infants J. Clin. Virol. 53 2012 135 139
11. J.K. Kim, and et al. Epidemiology of respiratory viral infection using multiplex RT-PCR in Cheonan, Korea (2006-2010) J. Microbiol. Biotechnol. 23 2013 267 273
12. R.K. Dare, and et al. Human coronavirus infections in rural Thailand: a comprehensive study using real-time reverse-transcription polymerase chain reaction assays J. Infect. Dis. 196 2007 1321 1328
13. M.M. Prill, and et al. Human coronavirus in young children hospitalized for acute respiratory illness and asymptomatic controls Pediatr. Infect. Dis. J. 31 2012 235 240
14. T.K. Cabeça, and et al. Epidemiological and clinical features of human coronavirus infections among different subsets of patients Influenza Other Respir. Viruses 7 2013 1040 1047
15. R. Lu, and et al. Characterization of human coronavirus etiology in Chinese adults with acute upper respiratory tract infection by real-time RT-PCR assays PLoS One 7 2012 e38638
16. Q. Lepiller, and et al. High incidence but low burden of coronaviruses and preferential associations between respiratory viruses J. Clin. Microbiol. 51 2013 3039 3046
17. L. van der Hoek Human coronaviruses: what do they cause? Antivir Ther. 12 2007 651 658
18. K. Pyrc, and et al. The novel human coronaviruses NL63 and HKU1 J. Virol. 81 2007 3051 3057
19. L. van der Hoek, and et al. Croup is associated with the novel coronavirus NL63 PLoS Med 2 2005 e240
20. A. Zumla, and et al. Middle East respiratory syndrome Lancet 386 2015 995 1007
21. S. Perlman The Middle East respiratory syndrome - how worried should we be? MBio 4 2013 e00531 e613
22. S.K. Lau, and et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats Proc. Natl. Acad. Sci. U. S. A. 102 2005 14040 14045
23. W. Li, and et al. Bats are natural reservoirs of SARS-like coronaviruses Science 310 2005 676 679
24. D.K. Chu, and et al. MERS coronaviruses in dromedary camels, Egypt Emerg. Infect. Dis. 20 2014 1049 1053
25. B.L. Haagmans, and et al. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation Lancet Infect. Dis. 14 2014 140 145
26. M.G. Hemida, and et al. MERS coronavirus in dromedary camel herd, Saudi Arabia Emerg. Infect. Dis. 20 2014 1231 1234
27. J.R. St-Jean, and et al. Human respiratory coronavirus OC43: genetic stability and neuroinvasion J. Virol. 78 2004 8824 8834
28. K. Stadler, and et al. SARS - beginning to understand a new virus Nat. Rev. Microbiol. 1 2003 209 218
29. P.S. Masters, and et al. Structure and function studies of the nucleocapsid protein of mouse hepatitis virus Adv. Exp. Med. Biol. 276 1990 239 246
30. P.S. Masters, and L.S. Sturman Background paper. Functions of the coronavirus nucleocapsid protein Adv. Exp. Med. Biol. 276 1990 235 238
31. F. Almazan, and et al. The nucleoprotein is required for efficient coronavirus genome replication J. Virol. 78 2004 12683 12688
32. B. Schelle, and et al. Selective replication of coronavirus genomes that express nucleocapsid protein J. Virol. 79 2005 6620 6630
33. S. Zuniga, and et al. Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription J. Virol. 84 2010 2169 2175
34. P.K. Hsieh, and et al. Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent J. Virol. 79 2005 13848 13855
35. S.A. Kopecky-Bromberg, and et al. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists J. Virol. 81 2007 548 557
36. L. Du, and et al. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection Vaccine 26 2008 1644 1651
37. M. Surjit, and et al. The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells J. Biol. Chem. 281 2006 10669 10681
38. T.K. Tang, and et al. Biochemical and immunological studies of nucleocapsid proteins of severe acute respiratory syndrome and 229E human coronaviruses Proteomics 5 2005 925 937
39. K.H. Chan, and et al. Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63 Clin. Diagn. Lab. Immunol. 12 2005 1317 1321
40. T. Mourez, and et al. Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of a western blot assay for detection of human antibodies against HCoV-OC43 J. Virol. Methods 139 2007 175 180
41. S.Y. Lin, and et al. Structural basis for the identification of the N-terminal domain of coronavirus nucleocapsid protein as an antiviral target J. Med. Chem. 57 2014 2247 2257
42. S. Chenavas, and et al. Influenza virus nucleoprotein: structure, RNA binding, oligomerization and antiviral drug target Future Microbiol. 8 2013 1537 1545
43. R.A. Musah The HIV-1 nucleocapsid zinc finger protein as a target of antiretroviral therapy Curr. Top. Med. Chem. 4 2004 1605 1622
44. C.K. Chang, and et al. Modular organization of SARS coronavirus nucleocapsid protein J. Biomed. Sci. 13 2006 59 72
45. I.M. Yu, and et al. Crystal structure of the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein dimerization domain reveals evolutionary linkage between corona- and arteriviridae J. Biol. Chem. 281 2006 17134 17139
46. C.Y. Chen, and et al. Structure of the SARS coronavirus nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for helical packaging of viral RNA J. Mol. Biol. 368 2007 1075 1086
47. C.K. Chang, and et al. The SARS coronavirus nucleocapsid protein - forms and functions Antiviral. Res. 103 2014 39 50
48. H. Luo, and et al. Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsid protein: self-association analysis and nucleic acid binding characterization Biochemistry 45 2006 11827 11835
49. Y. Ma, and et al. Structures of the N- and C-terminal domains of MHV-A59 nucleocapsid protein corroborate a conserved RNA-protein binding mechanism in coronavirus Protein Cell 1 2010 688 697
50. M. Takeda, and et al. Solution structure of the c-terminal dimerization domain of SARS coronavirus nucleocapsid protein solved by the SAIL-NMR method J. Mol. Biol. 380 2008 608 622
51. C.K. Chang, and et al. Multiple nucleic acid binding sites and intrinsic disorder of severe acute respiratory syndrome coronavirus nucleocapsid protein: implications for ribonucleocapsid protein packaging J. Virol. 83 2009 2255 2264
52. T.Y. Peng, and et al. Phosphorylation of the arginine/serine dipeptide-rich motif of the severe acute respiratory syndrome coronavirus nucleocapsid protein modulates its multimerization, translation inhibitory activity and cellular localization FEBS J. 275 2008 4152 4163
53. M. Surjit, and et al. The severe acute respiratory syndrome coronavirus nucleocapsid protein is phosphorylated and localizes in the cytoplasm by 14-3-3-mediated translocation J. Virol. 79 2005 11476 11486
54. C.H. Wu, and et al. Glycogen synthase kinase-3 regulates the phosphorylation of severe acute respiratory syndrome coronavirus nucleocapsid protein and viral replication J. Biol. Chem. 284 2009 5229 5239
55. I.J. Chen, and et al. Crystal structure-based exploration of the important role of Arg106 in the RNA-binding domain of human coronavirus OC43 nucleocapsid protein Biochim. Biophys. Acta 1834 2013 1054 1062
56. N.E. Grossoehme, and et al. Coronavirus N protein N-terminal domain (NTD) specifically binds the transcriptional regulatory sequence (TRS) and melts TRS-cTRS RNA duplexes J. Mol. Biol. 394 2009 544 557
57. Y.W. Tan, and et al. Amino acid residues critical for RNA-binding in the N-terminal domain of the nucleocapsid protein are essential determinants for the infectivity of coronavirus in cultured cells Nucleic Acids Res. 34 2006 4816 4825
58. Y.S. Lo, and et al. Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein FEBS Lett. 587 2013 120 127
59. C.K. Chang, and et al. Transient oligomerization of the SARS-CoV N protein - implication for virus ribonucleoprotein packaging PLoS One 8 2013 e65045
60. H. Jayaram, and et al. X-ray structures of the N- and C-terminal domains of a coronavirus nucleocapsid protein: implications for nucleocapsid formation J. Virol. 80 2006 6612 6620
61. C.Y. Huang, and et al. Elucidation of the stability and functional regions of the human coronavirus OC43 nucleocapsid protein Protein Sci. 18 2009 2209 2218
62. E.O. Caul, and S.I. Egglestone Coronavirus-like particles present in simian faeces Vet. Rec. 104 1979 168 169
63. H.A. Davies, and et al. Ribonucleoprotein of avian infectious bronchitis virus J. Gen. Virol. 53 1981 67 74
64. M.R. Macnaughton, and M.H. Madge The genome of human coronavirus strain 229E J. Gen. Virol. 39 1978 497 504
65. B.W. Neuman, and et al. Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy J. Virol. 80 2006 7918 7928
66. M. Bárcena, and et al. Cryo-electron tomography of mouse hepatitis virus: insights into the structure of the coronavirion Proc. Natl. Acad. Sci. U. S. A. 106 2009 582 587
67. H.J. Dyson Roles of intrinsic disorder in protein-nucleic acid interactions Mol. Biosyst. 8 2012 97 104
68. S.R. Compton, and et al. In vitro replication of mouse hepatitis virus strain A59 J. Virol. 61 1987 1814 1820
69. V.J. Hilser, and E.B. Thompson Intrinsic disorder as a mechanism to optimize allosteric coupling in proteins Proc. Natl. Acad. Sci. U. S. A. 104 2007 8311 8315
70. A. Zlotnick Are weak protein-protein interactions the general rule in capsid assembly? Virology 315 2003 269 274
71. L. Kuo, and et al. Recognition of the murine coronavirus genomic RNA packaging signal depends on the second RNA-binding domain of the nucleocapsid protein J. Virol. 88 2014 4451 4465
72. A. Monod, and et al. Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenza Expert Opin. Drug Discov. 10 2015 345 371
73. A.D. Kwong, and et al. Viral and cellular RNA helicases as antiviral targets Nat. Rev. Drug Discov. 4 2005 845 853
74. S. Crowder, and K. Kirkegaard Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses Nat. Genet. 37 2005 701 709
75. C. Cianci, and et al. Influenza nucleoprotein: promising target for antiviral chemotherapy Antivir. Chem. Chemother. 23 2013 77 91
76. B. Tarus, and et al. Structure-based design of novel naproxen derivatives targeting monomeric nucleoprotein of influenza A virus J. Biomol. Struct. Dyn. 33 2015 1899 1912
77. N. Lejal, and et al. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus Antimicrob. Agents Chemother. 57 2013 2231 2242
78. H.C. Hung, and et al. Development of an anti-influenza drug screening assay targeting nucleoproteins with tryptophan fluorescence quenching Anal. Chem. 84 2012 6391 6399
79. S.W. Gerritz, and et al. Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers Proc. Natl. Acad. Sci. U. S. A. 108 2011 15366 15371
80. S.-Y. Lin, and et al. Structural basis for the identification of the N-terminal domain of coronavirus nucleocapsid protein as an antiviral target J. Med. Chem. 57 2014 2247 2257
81. C-k. Chang, and et al. Structure-based virtual screening and experimental validations for discovery of inhibitors targeted towards the human coronavirus nucleocapsid protein Mol. BioSyst. 2015 10.1039/C5MB00582E
82. Z. Hayouka, and et al. Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium Proc. Natl. Acad. Sci. U. S. A. 104 2007 8316 8321
83. A. Pujol, and et al. Inhibition of parvovirus minute virus of mice replication by a peptide involved in the oligomerization of nonstructural protein NS1 J. Virol. 71 1997 7393 7403
84. Y.F. Shen, and et al. E339...R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors Proc. Natl. Acad. Sci. U. S. A. 108 2011 16515 16520
85. C. Roh A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide Int. J. Nanomedicine 7 2012 2173 2179
86. M.S. Zhu, and et al. Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine Immunol. Lett. 92 2004 237 243
87. P. Zhao, and et al. Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine Virology 331 2005 128 135
88. B. Bai, and et al. Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses Mol. Immunol. 45 2008 868 875
89. M. Liniger, and et al. Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses Vaccine 26 2008 2164 2174
90. K. Schulze, and et al. A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus Vaccine 26 2008 6678 6684
91. K. Yang, and et al. Immune responses to T-cell epitopes of SARS CoV-N protein are enhanced by N immunization with a chimera of lysosome-associated membrane protein Gene Ther. 16 2009 1353 1362
92. T.W. Kim, and et al. Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus J. Virol. 78 2004 4638 4645
93. S.J. Liu, and et al. Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates Vaccine 24 2006 3100 3108
94. J. Zhao, and et al. Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus J. Virol. 81 2007 6079 6088
95. Y.K. Cheung, and et al. Induction of T-cell response by a DNA vaccine encoding a novel HLA-A∗0201 severe acute respiratory syndrome coronavirus epitope Vaccine 25 2007 6070 6077
96. D. Deming, and et al. Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants PLoS Med. 3 2006 e525
97. P. Wongyanin, and et al. Role of porcine reproductive and respiratory syndrome virus nucleocapsid protein in induction of interleukin-10 and regulatory T-lymphocytes (Treg) J. Gen. Virol. 93 2012 1236 1246
98. >M. Bolles, and et al. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge J. Virol. 85 2011 12201 12215
99. A.O. Adedeji, and S.G. Sarafianos Antiviral drugs specific for coronaviruses in preclinical development Curr. Opin. Virol. 8 2014 45 53
100. R. Hilgenfeld, and M. Peiris From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses Antiviral Res. 100 2013 286 295
101. R.L. Graham, and et al. A decade after SARS: strategies for controlling emerging coronaviruses Nat. Rev. Microbiol. 11 2013 836 848
102. A.S. Omrani, and et al. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study Lancet Infect. Dis. 14 2014 1090 1095
103. R. Hilgenfeld From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design FEBS J. 281 2014 4085 4096
104. Y.S. Keum, and Y.J. Jeong Development of chemical inhibitors of the SARS coronavirus: viral helicase as a potential target Biochem. Pharmacol. 84 2012 1351 1358
105. Y.S. Wang, and et al. Crystallographic analysis of the N-terminal domain of Middle East respiratory syndrome coronavirus nucleocapsid protein Acta Crystallogr. F: Struct. Biol. Commun. 71 2015 977 980
106. Z. Zhang, and et al. Identification of cavities on protein surface using multiple computational approaches for drug binding site prediction Bioinformatics 27 2011 2083 2088